Versant Capital Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$87K Sell
4,405
-5,560
-56% -$140K 0.01% 1028
2026
Q2
$285K Buy
9,965
+970
+11% +$30.8K 0.03% 486
2026
Q1
$283K Buy
8,995
+1,408
+19% +$44.4K 0.03% 461
2025
Q4
$224K Buy
7,587
+673
+10% +$18.7K 0.03% 458
2025
Q3
$175K Buy
6,914
+1,352
+24% +$33K 0.02% 517
2025
Q2
$133K Sell
5,562
-679
-11% -$15.7K 0.02% 570
2025
Q1
$143K Buy
+6,241
New +$151K 0.02% 513

Other funds holding RTO

Versant Capital Management's RTO Position: Q3 2026 in Review

Versant Capital Management reduced its Rentokil (RTO) stake by 56% in Q3 2026, selling an estimated $140K and leaving 4,405 shares worth $87K. The position accounts for 0.01% of the portfolio, ranked #1028.

Versant Capital Management first reported a position in RTO in Q1 2025 and has held it in 7 quarters since. The position peaked at $285K in Q2 2026. 107 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Versant Capital Management held 4,405 shares of Rentokil worth $87K as of Q3 2026.
  • Versant Capital Management sold 5,560 Rentokil shares in Q3 2026, an estimated $140K.
  • Rentokil made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #1028 holding.
  • Versant Capital Management first reported a position in Rentokil in Q1 2025 and has held it in 7 quarters since.
  • Versant Capital Management's Rentokil position peaked at $285K in Q2 2026.
  • 107 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.